Sagimet Biosciences Announces Acceptance of Two Abstracts at AASLD – The Liver Meeting® 2023

SAN MATEO, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company …